Author correction to “FGF4 protects the liver from immune-mediated injury by activating CaMKKβ-PINK1 signal pathway to inhibit hepatocellular apoptosis” [Acta Pharm Sin B 14 (2024) 1605–1623]

Available online 9 April 2024

Acta Pharmaceutica Sinica B

Author links open overlay panel, , , , , , , , , , , , , , ,

© 2024 The Author(s). Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.

View original article

ACTA PHARMACEUTICA SINICA B

0 0 0 0 0 0 0

Comments (0)